Skip to main content
. 2022 Feb 25;26(8):615–625. doi: 10.1007/s10151-022-02600-5

Table 6.

Efficacy outcomes (disease recurrence)

All (n = 213) Group A (n = 144) Group B (n = 69) p value
Recurrence at 3 months 0.488
  No: n (%) 212 (99.5) 143 (99.3) 69 (100.0)
  Yes: n (%) 1 (0.5) 1 (0.7) 0 (0.0)
  Deceased: n (%) 0 (0.0) 0 (0.0) 0 (0.0)
(n = 212) (n = 143) (n = 69)
Recurrence at 6 months 0.366
  No: n (%) 207 (99.5) 140 (97.9) 67 (97.1)
  Yes: n (%) 4 (1.9) 3 (2.1) 1 (1.4)
  Deceased: n (%) 1 (0.5) 0 (0.0) 1 (1.4)
(n = 207) (n = 140) (n = 67)
Recurrence at 9 months 0.448
  No: n (%) 191 (92.3) 130 (92.9) 61 (91.0)
  Yes: n (%) 15 (7.2) 9 (6.4) 6 (9.0)
  Deceased: n (%) 1 (0.5) 1 (0.7) 0 (0.0)
(n = 191) (n = 130) (n = 61)
Recurrence at 12 months 0.894
  No: n (%) 173 (90.6) 118 (90.8) 55 (90.2)
  Yes: n (%) 18 (9.4) 12 (9.2) 6 (9.8)
  Deceased: n (%) 0 (0.0) 0 (0.0) 0 (0.0)

Tests used to compare variables between groups: Chi-square test